Loading…

Differences in clinical characteristics and disease‐free survival for Latino, African American, and non‐Latino white men with localized prostate cancer

BACKGROUND Few studies of ethnicity and prostate cancer have included Latino men in analyses of baseline clinical characteristics, treatment selection, and disease‐free survival (DFS). The present study examines the impact of Latino ethnicity on these parameters in a large, multiinstitutional databa...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 2006-02, Vol.106 (4), p.789-795
Main Authors: Latini, David M., Elkin, Eric P., Cooperberg, Matthew R., Sadetsky, Natalia, DuChane, Janeen, Carroll, Peter R.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1195-9c2750520fb58ffed2a03f219b2baa6a4daeefb4ebf340238f9bc26dff744a723
cites
container_end_page 795
container_issue 4
container_start_page 789
container_title Cancer
container_volume 106
creator Latini, David M.
Elkin, Eric P.
Cooperberg, Matthew R.
Sadetsky, Natalia
DuChane, Janeen
Carroll, Peter R.
description BACKGROUND Few studies of ethnicity and prostate cancer have included Latino men in analyses of baseline clinical characteristics, treatment selection, and disease‐free survival (DFS). The present study examines the impact of Latino ethnicity on these parameters in a large, multiinstitutional database of men with prostate cancer. METHODS We compared baseline disease characteristics and clinical outcomes for Latino (N = 138), non‐Latino White (NLW, N = 5619), and African‐American (AA, N = 608) men with localized prostate cancer by using chi‐square and ANOVA for baseline variables and survival analysis to examine differences in time to recurrence. RESULTS Latino men resembled AA men more than NLW on sociodemographic characteristics. AA men had higher Gleason scores and prostate‐specific antigen (PSA) at diagnosis than Latino or NLW men (both P < 0.01). 10% of both Latino and AA men presented with advanced disease (T3b/T4/N+/M+) versus 4% of NLW (P < 0.01). Latino men did not receive different treatments than NLW or AA men after controlling for clinical and demographic factors; however, AA men were more likely to receive external beam radiation (OR = 1.51, 95% confidence interval [CI] = 0.99–2.31) and hormone treatment (OR = 1.56, 95% CI = 1.05–2.32) then NLW men. For prostatectomy patients, 3‐year actuarial DFS rates were 83% for NLW men and 86% for Latino men versus 69% for AA men (P < 0.01). After controlling for clinical and sociodemographic variables, AA men were somewhat more likely than NLW to experience disease recurrence after radical prostatectomy (RP) (HR = 1.38, 95% CI = 0.98–1.94, P = 0.06). CONCLUSIONS Latinos are more similar to African Americans on sociodemographic characteristics but more similar to NLW on clinical presentation, treatments received, and DFS. Cancer 2006. © 2006 American Cancer Society. This study compared baseline disease characteristics and clinical outcomes for Latino, non‐Latino White, and African‐American men with localized prostate cancer. Latinos are more similar to African Americans on sociodemographic characteristics but more similar to non‐Latino Whites on clinical presentation and disease‐free survival rates. These results add new information to our understanding of the relation among ethnicity, sociodemographics, clinical characteristics, and outcomes of men with prostate cancer.
doi_str_mv 10.1002/cncr.21675
format article
fullrecord <record><control><sourceid>wiley</sourceid><recordid>TN_cdi_wiley_primary_10_1002_cncr_21675_CNCR21675</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CNCR21675</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1195-9c2750520fb58ffed2a03f219b2baa6a4daeefb4ebf340238f9bc26dff744a723</originalsourceid><addsrcrecordid>eNotkE1OwzAQhS0EEqWw4QQ-QFP8l6ZZVuFXqkBCILGLJs5YNUqdyg6NyoojsOd2nAQ3ZTVvNO-b0TxCLjmbcsbElXbaTwWfZekRGXGWZwnjShyTEWNsnqRKvp2SsxDeY5uJVI7Iz7U1Bj06jYFaR3VjndXQUL0CD7pDb0NndaDgalrbgBDw9-vbeEQaPvzWbqPXtJ4uobOundCF8ZF3dLHGQUwG0rUuUgcP7Ve2Q7pGR3vbrWjTxnv2E2u68W3oIM4ip9GfkxMDTcCL_zomr7c3L8V9sny6eygWy0RznqdJrkWWslQwU6Xz-EwtgEkjeF6JCmAGqgZEUymsjFRMyLnJKy1mtTGZUpAJOSb8sLe3De7Kjbdr8LuSs3KfabnPtBwyLYvH4nlQ8g_hD3L4</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Differences in clinical characteristics and disease‐free survival for Latino, African American, and non‐Latino white men with localized prostate cancer</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><source>EZB Electronic Journals Library</source><creator>Latini, David M. ; Elkin, Eric P. ; Cooperberg, Matthew R. ; Sadetsky, Natalia ; DuChane, Janeen ; Carroll, Peter R.</creator><creatorcontrib>Latini, David M. ; Elkin, Eric P. ; Cooperberg, Matthew R. ; Sadetsky, Natalia ; DuChane, Janeen ; Carroll, Peter R.</creatorcontrib><description>BACKGROUND Few studies of ethnicity and prostate cancer have included Latino men in analyses of baseline clinical characteristics, treatment selection, and disease‐free survival (DFS). The present study examines the impact of Latino ethnicity on these parameters in a large, multiinstitutional database of men with prostate cancer. METHODS We compared baseline disease characteristics and clinical outcomes for Latino (N = 138), non‐Latino White (NLW, N = 5619), and African‐American (AA, N = 608) men with localized prostate cancer by using chi‐square and ANOVA for baseline variables and survival analysis to examine differences in time to recurrence. RESULTS Latino men resembled AA men more than NLW on sociodemographic characteristics. AA men had higher Gleason scores and prostate‐specific antigen (PSA) at diagnosis than Latino or NLW men (both P &lt; 0.01). 10% of both Latino and AA men presented with advanced disease (T3b/T4/N+/M+) versus 4% of NLW (P &lt; 0.01). Latino men did not receive different treatments than NLW or AA men after controlling for clinical and demographic factors; however, AA men were more likely to receive external beam radiation (OR = 1.51, 95% confidence interval [CI] = 0.99–2.31) and hormone treatment (OR = 1.56, 95% CI = 1.05–2.32) then NLW men. For prostatectomy patients, 3‐year actuarial DFS rates were 83% for NLW men and 86% for Latino men versus 69% for AA men (P &lt; 0.01). After controlling for clinical and sociodemographic variables, AA men were somewhat more likely than NLW to experience disease recurrence after radical prostatectomy (RP) (HR = 1.38, 95% CI = 0.98–1.94, P = 0.06). CONCLUSIONS Latinos are more similar to African Americans on sociodemographic characteristics but more similar to NLW on clinical presentation, treatments received, and DFS. Cancer 2006. © 2006 American Cancer Society. This study compared baseline disease characteristics and clinical outcomes for Latino, non‐Latino White, and African‐American men with localized prostate cancer. Latinos are more similar to African Americans on sociodemographic characteristics but more similar to non‐Latino Whites on clinical presentation and disease‐free survival rates. These results add new information to our understanding of the relation among ethnicity, sociodemographics, clinical characteristics, and outcomes of men with prostate cancer.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.21675</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>ethnicity ; longitudinal analysis ; prostatic neoplasms</subject><ispartof>Cancer, 2006-02, Vol.106 (4), p.789-795</ispartof><rights>Copyright © 2006 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1195-9c2750520fb58ffed2a03f219b2baa6a4daeefb4ebf340238f9bc26dff744a723</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Latini, David M.</creatorcontrib><creatorcontrib>Elkin, Eric P.</creatorcontrib><creatorcontrib>Cooperberg, Matthew R.</creatorcontrib><creatorcontrib>Sadetsky, Natalia</creatorcontrib><creatorcontrib>DuChane, Janeen</creatorcontrib><creatorcontrib>Carroll, Peter R.</creatorcontrib><title>Differences in clinical characteristics and disease‐free survival for Latino, African American, and non‐Latino white men with localized prostate cancer</title><title>Cancer</title><description>BACKGROUND Few studies of ethnicity and prostate cancer have included Latino men in analyses of baseline clinical characteristics, treatment selection, and disease‐free survival (DFS). The present study examines the impact of Latino ethnicity on these parameters in a large, multiinstitutional database of men with prostate cancer. METHODS We compared baseline disease characteristics and clinical outcomes for Latino (N = 138), non‐Latino White (NLW, N = 5619), and African‐American (AA, N = 608) men with localized prostate cancer by using chi‐square and ANOVA for baseline variables and survival analysis to examine differences in time to recurrence. RESULTS Latino men resembled AA men more than NLW on sociodemographic characteristics. AA men had higher Gleason scores and prostate‐specific antigen (PSA) at diagnosis than Latino or NLW men (both P &lt; 0.01). 10% of both Latino and AA men presented with advanced disease (T3b/T4/N+/M+) versus 4% of NLW (P &lt; 0.01). Latino men did not receive different treatments than NLW or AA men after controlling for clinical and demographic factors; however, AA men were more likely to receive external beam radiation (OR = 1.51, 95% confidence interval [CI] = 0.99–2.31) and hormone treatment (OR = 1.56, 95% CI = 1.05–2.32) then NLW men. For prostatectomy patients, 3‐year actuarial DFS rates were 83% for NLW men and 86% for Latino men versus 69% for AA men (P &lt; 0.01). After controlling for clinical and sociodemographic variables, AA men were somewhat more likely than NLW to experience disease recurrence after radical prostatectomy (RP) (HR = 1.38, 95% CI = 0.98–1.94, P = 0.06). CONCLUSIONS Latinos are more similar to African Americans on sociodemographic characteristics but more similar to NLW on clinical presentation, treatments received, and DFS. Cancer 2006. © 2006 American Cancer Society. This study compared baseline disease characteristics and clinical outcomes for Latino, non‐Latino White, and African‐American men with localized prostate cancer. Latinos are more similar to African Americans on sociodemographic characteristics but more similar to non‐Latino Whites on clinical presentation and disease‐free survival rates. These results add new information to our understanding of the relation among ethnicity, sociodemographics, clinical characteristics, and outcomes of men with prostate cancer.</description><subject>ethnicity</subject><subject>longitudinal analysis</subject><subject>prostatic neoplasms</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNotkE1OwzAQhS0EEqWw4QQ-QFP8l6ZZVuFXqkBCILGLJs5YNUqdyg6NyoojsOd2nAQ3ZTVvNO-b0TxCLjmbcsbElXbaTwWfZekRGXGWZwnjShyTEWNsnqRKvp2SsxDeY5uJVI7Iz7U1Bj06jYFaR3VjndXQUL0CD7pDb0NndaDgalrbgBDw9-vbeEQaPvzWbqPXtJ4uobOundCF8ZF3dLHGQUwG0rUuUgcP7Ve2Q7pGR3vbrWjTxnv2E2u68W3oIM4ip9GfkxMDTcCL_zomr7c3L8V9sny6eygWy0RznqdJrkWWslQwU6Xz-EwtgEkjeF6JCmAGqgZEUymsjFRMyLnJKy1mtTGZUpAJOSb8sLe3De7Kjbdr8LuSs3KfabnPtBwyLYvH4nlQ8g_hD3L4</recordid><startdate>20060215</startdate><enddate>20060215</enddate><creator>Latini, David M.</creator><creator>Elkin, Eric P.</creator><creator>Cooperberg, Matthew R.</creator><creator>Sadetsky, Natalia</creator><creator>DuChane, Janeen</creator><creator>Carroll, Peter R.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope/></search><sort><creationdate>20060215</creationdate><title>Differences in clinical characteristics and disease‐free survival for Latino, African American, and non‐Latino white men with localized prostate cancer</title><author>Latini, David M. ; Elkin, Eric P. ; Cooperberg, Matthew R. ; Sadetsky, Natalia ; DuChane, Janeen ; Carroll, Peter R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1195-9c2750520fb58ffed2a03f219b2baa6a4daeefb4ebf340238f9bc26dff744a723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>ethnicity</topic><topic>longitudinal analysis</topic><topic>prostatic neoplasms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Latini, David M.</creatorcontrib><creatorcontrib>Elkin, Eric P.</creatorcontrib><creatorcontrib>Cooperberg, Matthew R.</creatorcontrib><creatorcontrib>Sadetsky, Natalia</creatorcontrib><creatorcontrib>DuChane, Janeen</creatorcontrib><creatorcontrib>Carroll, Peter R.</creatorcontrib><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Latini, David M.</au><au>Elkin, Eric P.</au><au>Cooperberg, Matthew R.</au><au>Sadetsky, Natalia</au><au>DuChane, Janeen</au><au>Carroll, Peter R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differences in clinical characteristics and disease‐free survival for Latino, African American, and non‐Latino white men with localized prostate cancer</atitle><jtitle>Cancer</jtitle><date>2006-02-15</date><risdate>2006</risdate><volume>106</volume><issue>4</issue><spage>789</spage><epage>795</epage><pages>789-795</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>BACKGROUND Few studies of ethnicity and prostate cancer have included Latino men in analyses of baseline clinical characteristics, treatment selection, and disease‐free survival (DFS). The present study examines the impact of Latino ethnicity on these parameters in a large, multiinstitutional database of men with prostate cancer. METHODS We compared baseline disease characteristics and clinical outcomes for Latino (N = 138), non‐Latino White (NLW, N = 5619), and African‐American (AA, N = 608) men with localized prostate cancer by using chi‐square and ANOVA for baseline variables and survival analysis to examine differences in time to recurrence. RESULTS Latino men resembled AA men more than NLW on sociodemographic characteristics. AA men had higher Gleason scores and prostate‐specific antigen (PSA) at diagnosis than Latino or NLW men (both P &lt; 0.01). 10% of both Latino and AA men presented with advanced disease (T3b/T4/N+/M+) versus 4% of NLW (P &lt; 0.01). Latino men did not receive different treatments than NLW or AA men after controlling for clinical and demographic factors; however, AA men were more likely to receive external beam radiation (OR = 1.51, 95% confidence interval [CI] = 0.99–2.31) and hormone treatment (OR = 1.56, 95% CI = 1.05–2.32) then NLW men. For prostatectomy patients, 3‐year actuarial DFS rates were 83% for NLW men and 86% for Latino men versus 69% for AA men (P &lt; 0.01). After controlling for clinical and sociodemographic variables, AA men were somewhat more likely than NLW to experience disease recurrence after radical prostatectomy (RP) (HR = 1.38, 95% CI = 0.98–1.94, P = 0.06). CONCLUSIONS Latinos are more similar to African Americans on sociodemographic characteristics but more similar to NLW on clinical presentation, treatments received, and DFS. Cancer 2006. © 2006 American Cancer Society. This study compared baseline disease characteristics and clinical outcomes for Latino, non‐Latino White, and African‐American men with localized prostate cancer. Latinos are more similar to African Americans on sociodemographic characteristics but more similar to non‐Latino Whites on clinical presentation and disease‐free survival rates. These results add new information to our understanding of the relation among ethnicity, sociodemographics, clinical characteristics, and outcomes of men with prostate cancer.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><doi>10.1002/cncr.21675</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 2006-02, Vol.106 (4), p.789-795
issn 0008-543X
1097-0142
language eng
recordid cdi_wiley_primary_10_1002_cncr_21675_CNCR21675
source Wiley-Blackwell Read & Publish Collection; EZB Electronic Journals Library
subjects ethnicity
longitudinal analysis
prostatic neoplasms
title Differences in clinical characteristics and disease‐free survival for Latino, African American, and non‐Latino white men with localized prostate cancer
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T13%3A46%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differences%20in%20clinical%20characteristics%20and%20disease%E2%80%90free%20survival%20for%20Latino,%20African%20American,%20and%20non%E2%80%90Latino%20white%20men%20with%20localized%20prostate%20cancer&rft.jtitle=Cancer&rft.au=Latini,%20David%20M.&rft.date=2006-02-15&rft.volume=106&rft.issue=4&rft.spage=789&rft.epage=795&rft.pages=789-795&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.21675&rft_dat=%3Cwiley%3ECNCR21675%3C/wiley%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1195-9c2750520fb58ffed2a03f219b2baa6a4daeefb4ebf340238f9bc26dff744a723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true